Invention Grant
US08216583B2 Formulation of human antibodies for treating TNF-α associated disorders
有权
制备用于治疗TNF-α相关疾病的人抗体
- Patent Title: Formulation of human antibodies for treating TNF-α associated disorders
- Patent Title (中): 制备用于治疗TNF-α相关疾病的人抗体
-
Application No.: US10525292Application Date: 2003-08-15
-
Publication No.: US08216583B2Publication Date: 2012-07-10
- Inventor: Hans-Juergen Kruase , Lisa Baust , Michael Dickes
- Applicant: Hans-Juergen Kruase , Lisa Baust , Michael Dickes
- Applicant Address: BM Hamilton
- Assignee: Abbott Biotechnology, Ltd.
- Current Assignee: Abbott Biotechnology, Ltd.
- Current Assignee Address: BM Hamilton
- Agency: McCarter & English, LLP
- Agent Cristin H. Cowles; Deborah L. Nagle
- International Application: PCT/IB03/04502 WO 20030815
- International Announcement: WO2004/016286 WO 20040226
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/00 ; C07K16/22 ; C07K14/525
Abstract:
A liquid aqueous pharmaceutical formulation is described which has a high protein concentration, a pH of between about 4 and about 8, and enhanced stability.
Public/Granted literature
- US20060153846A1 Formulation of human antibodies for treating tnf-alpha associated disorders Public/Granted day:2006-07-13
Information query
